EBIT: Income before interest and taxes.
Kronos Bio, Inc. (KRON) had EBIT of $-33.83M for the most recently reported fiscal quarter, ending 2023-09-30.
Income Statement Financials | |
$0.92M |
|
$-31.37M |
|
-- |
|
$0.92M |
|
$34.74M |
|
$-33.83M |
|
$2.45M |
|
$-31.37M |
|
$-31.37M |
|
$-31.37M |
|
$-31.37M |
|
$-31.37M |
|
$-31.37M |
|
EBIT |
$-33.83M |
$-34.68M |
|
58.15M |
|
58.15M |
|
$-0.54 |
|
$-0.54 |
|
Balance Sheet Financials | |
$191.56M |
|
$11.31M |
|
$46.43M |
|
$237.99M |
|
$25.67M |
|
-- |
|
$33.70M |
|
$59.37M |
|
$178.62M |
|
$178.62M |
|
$178.62M |
|
58.18M |
|
Cash Flow Statement Financials | |
$-53.56M |
|
$34.81M |
|
$0.38M |
|
$78.00M |
|
$59.62M |
|
$-18.37M |
|
$19.81M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
7.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3688.66% |
|
-3688.66% |
|
-- |
|
-3421.37% |
|
-3421.37% |
|
$-54.21M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-17.56% |
|
-17.56% |
|
-13.18% |
|
-17.56% |
|
$3.07 |
|
$-0.93 |
|
$-0.92 |